8 Biopharma Trends to Watch in 2020
Election, mergers and acquisitions, Alzheimer’s drug, gene therapy, and genome editing are among biopharma industry’s likeliest drivers heading into the new year.
Related Articles
Synthetic Biology Encourages Cells to Keep on Producing
Enduro Genetics has developed genetic plugins featuring biosensors and promoters that can detect and regulate mAb production levels in cells.
Cutting mAb Costs and Boosting Access in Low- and Middle-Income Countries
Moving away from batch-mode production and using higher-yield cell lines are also options for mAb makers looking to reduce production costs.
Chemo-Enzymatic Method for Making sgRNA Triples Yield and Improves Purity
For successful assembly using this process, researchers stress that buffer preparation is critical.
Where is Bioprocessing Going Globally?
Where is bioprocessing taking place around the world, and what can we learn from ongoing trends in the global economy?
Improving CGT Production to Speed Delivery and Lower Cost
From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more affordably.
Sustainability in Pharma Manufacturing: Strategic Benefits of Going Green
Greener supply chains positively impact environmental and business outcomes.
Cytiva Completes $1.6 billion in Strategic Investments to Further Enhance Global Supply Chain
Cytiva notes that its latest capacity investments are also expanding “in-region, for region” manufacturing of single-use bags.
Viral Ribosome Profiling Could Speed Vaccine Development
Massively Parallel Ribosome Profiling (MPRP) enables rapid identification of viral proteins without the need to grow live viruses.
Knot a Problem: Mechanism Found for DNA Loop Control
Disrupting the G-loop cycle causes transcriptome dysregulation and genome instability, revealing key role in cell survival and homeostasis.
Rapid Formation of Vascular Organoids from iPSCs via TF Activation
A dual transcription factor activation method enables rapid generation of vascular organoids, accelerating modeling and therapy development.